Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Karima Amaador"'
Autor:
Karima Amaador, Marie José Kersten, Hein P. J. Visser, Laurens Nieuwenhuizen, Roelandt F. J. Schop, Martine E. D. Chamuleau, Gerjo A. Velders, Monique C. Minnema, Josephine Mathilde Iris Vos
Publikováno v:
Hemato, Vol 3, Iss 4, Pp 704-717 (2022)
Waldenström macroglobulinemia (WM) is a rare B-cell Non-Hodgkin Lymphoma. There are only few prospective randomized clinical trials to guide treatment recommendations and there is no international consensus on a preferred first line treatment approa
Externí odkaz:
https://doaj.org/article/82f4cd8b98654e7fb1dcdbb12f8fdac0
Autor:
Fritz Offner, Karima Amaador, Kazem Nasserinejad, Dries Deeren, Efstathios Kastritis, Steven T. Pals, Willem Kraan, Jeanette K. Doorduijn, Roberto D Liu, Monique C. Minnema, Marcel Kap, Marie José Kersten, Lara H Böhmer, Lidwine W. Tick, Meletios A. Dimopoulos, Josephine M.I. Vos, Martine E D Chamuleau, Maria Gavriatopoulou
Publikováno v:
JOURNAL OF CLINICAL ONCOLOGY
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 40(1), 40-51. American Society of Clinical Oncology
Kersten, M J, Amaador, K, Minnema, M C, Vos, J M I, Nasserinejad, K, Kap, M, Kastritis, E, Gavriatopoulou, M, Kraan, W, Chamuleau, M E D, Deeren, D, Tick, L W, Doorduijn, J K, Offner, F, Böhmer, L H, Liu, R D, Pals, S T & Dimopoulos, M A 2022, ' Combining Ixazomib With Subcutaneous Rituximab and Dexamethasone in Relapsed or Refractory Waldenström's Macroglobulinemia : Final Analysis of the Phase I/II HOVON124/ECWM-R2 Study ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 40, no. 1, pp. 40-51 . https://doi.org/10.1200/JCO.21.00105
Journal of clinical oncology, 40(1), 40-51. American Society of Clinical Oncology
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 40(1), 40-51. American Society of Clinical Oncology
Kersten, M J, Amaador, K, Minnema, M C, Vos, J M I, Nasserinejad, K, Kap, M, Kastritis, E, Gavriatopoulou, M, Kraan, W, Chamuleau, M E D, Deeren, D, Tick, L W, Doorduijn, J K, Offner, F, Böhmer, L H, Liu, R D, Pals, S T & Dimopoulos, M A 2022, ' Combining Ixazomib With Subcutaneous Rituximab and Dexamethasone in Relapsed or Refractory Waldenström's Macroglobulinemia : Final Analysis of the Phase I/II HOVON124/ECWM-R2 Study ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 40, no. 1, pp. 40-51 . https://doi.org/10.1200/JCO.21.00105
Journal of clinical oncology, 40(1), 40-51. American Society of Clinical Oncology
PURPOSE Proteasome inhibitors are effective in Waldenström's macroglobulinemia (WM) but require parenteral administration and are associated with polyneuropathy. We investigated efficacy and toxicity of the less neurotoxic oral proteasome inhibitor
Publikováno v:
HemaSphere, 5(2). Wolters Kluwer Health
HemaSphere
HemaSphere, Vol 5, Iss 2, p e527 (2021)
HemaSphere
HemaSphere, Vol 5, Iss 2, p e527 (2021)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38d242a05e1e1c42f24b0b73a045ca41
https://pure.amc.nl/en/publications/what-the-silent-retina-tells-you(8b2d1dc1-ff76-4efe-b490-edee8527cc8c).html
https://pure.amc.nl/en/publications/what-the-silent-retina-tells-you(8b2d1dc1-ff76-4efe-b490-edee8527cc8c).html
Autor:
Marie José Kersten, Avinash G. Dinmohamed, Eduardus F. M. Posthuma, Monique C. Minnema, Josephine M.I. Vos, Karima Amaador, Otto Visser
Publikováno v:
British journal of haematology. Wiley-Blackwell
British Journal of Haematology, 196(5), 1205-1208. Wiley-Blackwell Publishing Ltd
British Journal of Haematology, 196(5), 1205-1208. Wiley-Blackwell Publishing Ltd
Contemporary diagnosed WM patients, compared to the general population, continue to experience excess mortality regardless of having survived up to 15 years post-diagnosis. This gradual increase in excess mortality might result from the incurable nat
Autor:
Marie José Kersten, Monique C. Minnema, Karima Amaador, Josephine M.I. Vos, Pythia T. Nieuwkerk
Publikováno v:
Blood. 138:835-835
Introduction The management of Waldenström's Macroglobulinemia (WM), a rare and incurable B-cell non-Hodgkin lymphoma, has evolved in recent years. Treatment options are increasing including more modern targeted therapies. Therefore there are curren
Autor:
Karima Amaador, Keon de Heer, Luuk Wieske, Filip Eftimov, Josephine M.I. Vos, Charlotte E. Teunissen, Marleen J. A. Koel-Simmelink, Marie José Kersten, Monique C. Minnema, Nicolette C. Notermans
Publikováno v:
Blood. 138:4733-4733
Introduction Peripheral neuropathies (PN) caused by immunoglobulin M (IgM) paraproteinemia are rare disorders that require close collaboration between hematologists and neurologists for adequate diagnosis and management. The IgM paraproteinemia is ca
Autor:
Karima Amaador, Maria Gavriatopoulou, Lidwine W. Tick, Roberto D Liu, Marie José Kersten, Steven T. Pals, Monique C. Minnema, Kazem Nasserinejad, Josephine M.I. Vos, Marcel Kap, Martine E.D. Chamuleau, Jeanette K. Doorduijn, Dries Deeren, Fritz Offner, Eftathios Kastritis, Lara H Böhmer, Meletios A. Dimopoulos
Publikováno v:
Blood. 134:344-344
Introduction Since no curative options for Waldenstrom's Macroglobulinemia (WM) are available, novel safe and effective treatments are needed. Several new agents, including BTK inhibitors and proteasome inhibitors (PIs) have shown considerable effica